BioTissue Completes Name Change

BioTissue Holdings announced the completion of its name change from TissueTech. The change is part of a corporate-wide branding initiative launched earlier this year to better represent the company’s entire portfolio and pipeline of products. Pursuant to the name change, the former TissueTech Inc. has become BioTissue Holdings Inc. and its subsidiaries BioTissue Inc. is now BioTissue Ocular Inc., and the former Amniox Medical, Inc. is now BioTissue Surgical Inc. 

“For over 25 years, the BioTissue name has been representative of leadership in ocular regenerative healing. Our name change allows us to showcase how our experience and expertise extends into the surgical space under the same trusted brand,” Ted Davis, president and CEO, BioTissue, said in a company news release. “Also, health care professionals and their patients can rest assured that we will continue to deliver the same high-quality products on which they rely.”

BioTissue’s innovative amniotic membrane product families Prokera, AmnioGraft, AmnioGuard, Neox, and Clarix will retain their brand names. All these products use the company’s proprietary CryoTek cryopreservation technology designed to retain the tissue’s structural and functional integrity.